Science and engineering

Sampling of Narrow Linewidth & High Output Power Micro ITLA for beyond-100Gbps optical digital coherent transmission

A new food web highlights which birds, fish, insects, and other animals affected by the Deepwater Horizon explosion in 2010 should receive top priority for conservation, protection, and research.

New research offers insights into how crystal dislocations — a common type of defect in materials — can affect electrical and heat transport through crystals, at a microscopic, quantum mechanical level.

In the center of a distant galaxy, almost 300 million light years from Earth, scientists have discovered a supermassive black hole that is “choking” on a sudden influx of stellar debris.

The research paper, published in The Journal of Pediatrics, says the effectiveness of internet filters is ‘dubious’ and suggests that resources would be better spent trying to develop the resilience of teenagers to such experiences.

New research clarifies how toroidal droplets—which initially take the shape of a donut—evolve into spherical droplets by collapsing into themselves or breaking up into smaller droplets.

Organoids are proving their worth in developmental biology and personalized medicine

KLM Cargo is honoured to be able to transport the giant pandas from Chengdu to their new enclosure in Ouwehands Zoo.

NEC Corporation (NEC; TSE: 6701) today announced that it trialed a system to dynamically create and utilize optimized networks by monitoring network traffic volumes and information tied to Internet of Things (IoT) devices, such as video cameras.

Rockwell Collins has been recognized by the Ethisphere Institute, a global leader in defining and advancing the standards of ethical business practices, as a 2017 World’s Most Ethical Company®.

Steven Universe is getting its own RPG called Save the Light, from Steven Universe co-creator Rebecca Sugar, Grumpyface Studios, and Cartoon Network. It's set to launch on PlayStation 4 later this year.

Vericel Corporation (NASDAQ:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today reported financial results and business highlights for the fourth quarter and year ended December 31, 2016